Indefinite Delivery Contract SPE2DX15D9630

The federal contract IDV awarded to DMS Pharmaceutical Group Inc. is a single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program. The contract, valued at $499,999,999 and valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. As a woman-owned small business, DMS Pharmaceutical Group leverages its status to secure direct federal awards for the delivery of these diverse pharmaceutical products and pharmacy services to Department of Defense healthcare sites, positioning the company as a crucial supplier in the federal pharmaceutical supply chain.